Skip to main content
. Author manuscript; available in PMC: 2016 Apr 15.
Published in final edited form as: Cancer Res. 2015 Mar 13;75(8):1682–1690. doi: 10.1158/0008-5472.CAN-14-1855

Figure 2. VEGF-A KD attenuates WM1617 and C8161 but not A2058 melanoma cell growth in vitro.

Figure 2

A, 2D Growth assays revealed that VEGF-A KD (sh1) inhibited WM1617 and C8161, but not A2058 melanoma cell growth in vitro. *, P<0.05. B, No change in colony formation was observed following VEGF-A KD (sh1) in WM1617, C8161 or A2058 melanoma cells. Data shown represent average percentage clonogenicity from three different experiments. Magnification, 100×. Scale bar: 500 µm. C, No change in vasculogenic mimicry as determined by tubule formation on matrigel per field was observed in WM1617, C8161 or A2058 VEGF-A KD (sh1) cells compared to controls in vitro. Magnification, 40×. Scale bar: 1 µm.